Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151.3 USD | +0.06% | +5.39% | -20.74% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.74% | 19.13B | |
+21.16% | 46.81B | |
-1.04% | 41.37B | |
+47.30% | 41.29B | |
-6.20% | 28.87B | |
+10.59% | 26.06B | |
+31.32% | 12.39B | |
+0.02% | 12.08B | |
-0.41% | 11.96B | |
+19.04% | 11.56B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Alnylam Pharmaceuticals : Guggenheim Downgrades Alnylam Pharmaceuticals to Neutral From Buy; Price Target is $162